Differences_NN
between_PIN
United_NN
Kingdom_NN
and_PHC
United_NN
States_NN
generally_RB
accepted_VBN [PRIV]
accounting_GER
principles_NN
for_PIN
the_DT
year_NN
ended_VBD
31_CD
December_NN
2002_CD
Profit_NN
and_PHC
loss_NN
account_NN
Adjustments_NOMZ
to_PIN
the_DT
loss_NN
for_PIN
the_DT
period_NN
under_IN
UK_NN
GAAP_NN
and_CC
the_DT
net_JJ
loss_NN
under_IN
US_FPP1
GAAP_NN
are_VPRT
as_IN
follows_VPRT
:_:
Year_NN
ended_VBD
Year_NN
ended_VBD
Notes_NN
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
Loss_NN
for_PIN
the_DT
period_NN
under_IN
UK_NN
GAAP_NN
45.8_CD
55.5_CD
US_FPP1
GAAP_NN
adjustments_NOMZ
:_:
Revenue_NN
recognition_NOMZ
i_FPP1
12.7_CD
13.1_CD
Medeva_NN
goodwill_NN
adjustments_NOMZ
ii_VPRT
3.6_CD
1.4_CD
Amortisation_NOMZ
of_PIN
goodwill_NN
and_CC
other_JJ
intangibles_NN
iii_FW
39.8_CD
14.6_CD
Inventory_NN
adjustment_NOMZ
iv_NN
0.8_CD
Pension_NN
costs_VPRT
1.9_CD
0.8_CD
Stock_NN
based_VBN
compensation_NOMZ
v_NN
7.2_CD
2.1_CD
Unrealised_JJ
gains_NN
on_PIN
derivative_JJ
financial_JJ
instruments_NOMZ
vi_FW
6.9_CD
0.4_CD
Deferred_VBN
taxation_NOMZ
vii_NN
5.1_CD
5.2_CD
Net_JJ
loss_NN
before_IN
cumulative_JJ
effect_NN
of_PIN
change_NN
in_PIN
accounting_GER
policy_NN
15.2_CD
87.3_CD
Cumulative_JJ
effect_NN
of_PIN
change_NN
in_PIN
accounting_GER
policy_NN
due_JJ
to_PIN
adoption_NOMZ
of_PIN
SFAS_NN
133_CD
vi_FW
1.5_CD
Net_JJ
loss_NN
as_IN
adjusted_VBN
to_TO
accord_VB
with_PIN
US_FPP1
GAAP_NN
15.2_CD
85.8_CD
Shareholders_NN
funds_NN
Adjustments_NOMZ
between_PIN
shareholders_NN
funds_NN
under_IN
UK_NN
GAAP_NN
and_PHC
US_FPP1
GAAP_NN
are_VPRT
as_IN
follows_VPRT
:_:
Year_NN
ended_VBD
Year_NN
ended_VBD
Notes_NN
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
Shareholders_NN
funds_NN
under_IN
UK_NN
GAAP_NN
564.4_CD
619.2_CD
US_FPP1
GAAP_NN
adjustments_NOMZ
:_:
Revenue_NN
recognition_NOMZ
i_FPP1
25.8_CD
13.1_CD
Goodwill_NN
and_PHC
intangibles_NN
iii_FW
163.2_CD
148.3_CD
Pensions_NN
0.2_CD
2.1_CD
Pensions_NN
other_JJ
comprehensive_JJ
income_NN
ix_NN
14.0_CD
Unrealised_JJ
gains_NN
on_PIN
derivative_JJ
financial_JJ
instruments_NOMZ
vi_VPRT
8.8_CD
1.9_CD
Employee_NN
Share_NN
Ownership_NN
Plan_NN
viii_NN
0.3_CD
0.3_CD
Deferred_VBN
taxation_NOMZ
vii_NN
5.1_CD
Shareholders_NN
funds_NN
as_IN
adjusted_VBN
to_TO
accord_VB
with_PIN
US_FPP1
GAAP_NN
696.5_CD
763.2_CD
Restated_VBN
in_PIN
accordance_NN
with_PIN
Form_NN
20F_CD
filed_VBN
with_PIN
the_DT
US_FPP1
SEC_NN
for_PIN
the_DT
year_NN
ended_VBD
31_CD
December_NN
2001_CD
._.
78_CD
Celltech_NN
Annual_JJ
Report_NN
2002_CD
Notes_NN
:_:
i_FPP1
Revenue_NN
recognition_NOMZ
Under_IN
UK_NN
GAAP_NN
,_,
non-refundable_JJ
licence_NN
fee_NN
revenue_NN
is_VPRT [PASS]
recognized_VBN [PRIV]
when_RB [WHCL]
earned_VBN
._.
Refundable_JJ
licence_NN
fees_NN
are_VPRT [PASS]
deferred_VBN
until_IN
such_JJ
time_NN
as_IN
they_TPP3
are_VPRT
no_RB
longer_RB
refundable_JJ
,_,
otherwise_CONJ
the_DT
individual_JJ
elements_NOMZ
such_JJ
as_IN
milestones_NN
and_PHC
R&D_NN
funding_GER
are_VPRT [PASS]
accounted_VBN
for_PIN
separately_RB
based_VBN
on_PIN
the_DT
revenue_NN
recognition_NOMZ
criteria_NN
set_VBN [WZPAST]
out_PIN
in_PIN
note_NN
1_CD
to_PIN
the_DT
accounts_NN
._.
US_FPP1
GAAP_NN
requires_VPRT [SUAV]
in_PIN
most_EMPH
circumstances_NN
the_DT
deferral_NN
of_PIN
non-refundable_JJ
upfront_JJ
licence_NN
fees_NN
and_CC
other_JJ
income_NN
received_VBN
under_IN
a_DT
contract_NN
where_RB
there_EX
is_VPRT
a_DT
continuing_VBG
involvement_NOMZ
with_PIN
the_DT
licensed_JJ
asset_NN
through_PIN
collaboration_NOMZ
or_CC
other_JJ
arrangement_NOMZ
._.
ii_FW
Medeva_FW
goodwill_NN
adjustments_NOMZ
Under_IN
US_FPP1
GAAP_NN
the_DT
time_NN
frame_NN
allowed_VBN [SUAV]
to_TO
make_VB
adjustments_NOMZ
to_PIN
goodwill_NN
is_VPRT [BEMA]
one_CD
year_NN
from_PIN
the_DT
date_NN
of_PIN
acquisition_NOMZ
,_,
except_PIN
for_PIN
adjustments_NOMZ
in_PIN
respect_NN
of_PIN
taxation_NOMZ
when_RB
an_DT
indefinite_JJ
period_NN
is_VPRT [BEMA]
available_PRED
._.
Under_IN
UK_NN
GAAP_NN
the_DT
time_NN
frame_NN
available_JJ
extends_VPRT
to_PIN
the_DT
first_JJ
full_JJ
reporting_GER
period_NN
after_IN
the_DT
reporting_GER
period_NN
in_PIN
which_WDT [PIRE]
the_DT
acquisition_NOMZ
was_VBD [PASS]
made_VBN
._.
Thus_CONJ
a_DT
longer_JJ
period_NN
to_TO
make_VB
goodwill_NN
adjustments_NOMZ
is_VPRT [BEMA]
generally_RB
available_PRED
under_IN
UK_NN
GAAP_NN
._.
Consequently_CONJ
certain_JJ
adjustments_NOMZ
were_VBD [PASS]
booked_VBN
to_PIN
goodwill_NN
arising_VBG [WZPRES]
on_PIN
the_DT
Medeva_NN
acquisition_NOMZ
during_PIN
2001_CD
for_PIN
the_DT
purpose_NN
of_PIN
the_DT
UK_NN
accounts_NN
._.
These_DEMP
have_VPRT [PEAS]
flowed_VBN
through_PIN
the_DT
profit_NN
and_PHC
loss_NN
account_NN
for_PIN
US_FPP1
GAAP_NN
purposes_NN
during_PIN
2001_CD
and_CC
2002_CD
._.
iii_FW
Amortisation_NOMZ
of_PIN
goodwill_NN
and_CC
other_JJ
intangibles_NN
Under_IN
US_FPP1
GAAP_NN
the_DT
merger_NN
between_PIN
Celltech_NN
and_PHC
Chiroscience_NN
failed_VBD
to_TO
qualify_VB
as_IN
a_DT
pooling_VBG
of_PIN
interest_NN
and_ANDC
therefore_CONJ
additional_JJ
goodwill_NN
and_CC
intangible_JJ
assets_NN
were_VBD [PASS]
established_VBN [PRIV]
on_PIN
the_DT
US_FPP1
balance_NN
sheet_NN
._.
In_CONJ
addition_NULL
,_,
amortisation_NOMZ
is_VPRT
no_RB
longer_RB
automatically_RB
charged_VBN
under_IN
SFAS_NN
142_CD
Goodwill_NN
and_CC
other_JJ
intangible_JJ
assets_NN
on_PIN
goodwill_NN
._.
Amortisation_NOMZ
continues_VPRT
to_TO
be_VB [PASS]
applied_VBN
in_PIN
the_DT
US_FPP1
on_PIN
finite_JJ
life_NN
intangibles_NN
whilst_OSUB
goodwill_NN
and_CC
indefinite_JJ
life_NN
intangibles_NN
are_VPRT [PASS]
tested_VBN
for_PIN
impairment_NOMZ
annually_RB
._.
iv_NN
Inventory_NN
adjustment_NOMZ
The_DT
2001_CD
adjustment_NOMZ
relates_VPRT
to_PIN
the_DT
Thiemann_NN
acquisition_NOMZ
and_CC
the_DT
2000_CD
adjustment_NOMZ
to_PIN
the_DT
Medeva_NN
acquisition_NOMZ
._.
Under_IN
UK_NN
GAAP_NN
,_,
inventory_NN
is_VPRT [PASS]
recognized_VBN [PRIV]
at_PIN
replacement_NOMZ
cost_NN
._.
Under_IN
US_FPP1
GAAP_NN
,_,
inventory_NN
is_VPRT [PASS]
recognized_VBN [PRIV]
at_PIN
selling_VBG
price_NN
less_RB
an_DT
allowance_NN
for_PIN
selling_VBG
costs_NN
._.
v_NN
Stock_NN
based_VBN
compensation_NOMZ
Under_IN
UK_NN
GAAP_NN
,_,
no_SYNE
compensation_NOMZ
expense_NN
is_VPRT [PASS]
recorded_VBN
in_PIN
connection_NOMZ
with_PIN
the_DT
issue_NN
of_PIN
share_NN
options_NOMZ
to_PIN
Group_NN
employees_NN
at_PIN
market_NN
value_NN
._.
Under_IN
US_FPP1
GAAP_NN
,_,
APB_NN
25_CD
,_,
an_DT
annual_JJ
compensation_NOMZ
expense_NN
is_VPRT [BEMA]
imputed_PRED
for_PIN
variable_JJ
stock_NN
option_NOMZ
plans_VPRT
based_VBN
on_PIN
the_DT
excess_NN
of_PIN
the_DT
then_RB
prevailing_VBG
market_NN
price_NN
over_IN
grant_NN
price_NN
._.
vi_FW
Unrealised_JJ
gains_NN
on_PIN
derivative_JJ
financial_JJ
instruments_NOMZ
As_IN
described_VBN
in_PIN
note_NN
1_CD
to_PIN
the_DT
accounts_NN
financial_JJ
instruments_NOMZ
the_DT
Group_NN
uses_VPRT
forward_RB
exchange_NN
contracts_NN
to_TO
match_VB
against_PIN
forecast_NN
receipts_NN
and_PHC
payments_NOMZ
in_PIN
foreign_JJ
currency_NN
._.
As_IN
the_DT
contracts_NN
are_VPRT [PASS]
not_XX0
matched_VBN
to_PIN
specific_JJ
receivables_NN
or_CC
payables_NN
the_DT
gains_NN
or_CC
losses_NN
arising_VBG [WZPRES]
on_PIN
the_DT
hedges_NN
are_VPRT [PASS]
not_XX0
recognized_VBN [PRIV]
until_IN
such_JJ
time_NN
as_IN
they_TPP3
are_VPRT [PASS]
realized_VBN [PRIV]
under_IN
UK_NN
GAAP_NN
._.
SFAS_NN
133_CD
determines_VPRT [SUAV] [PRIV]
that_THVC
under_IN
such_JJ
circumstances_NN
recognition_NOMZ
should_NEMD
be_VB [PASS]
made_VBN
of_PIN
the_DT
gains_NN
or_CC
losses_NN
that_TSUB
have_VPRT [PEAS]
arisen_VBN
in_PIN
the_DT
profit_NN
and_PHC
loss_NN
account_NN
._.
The_DT
Group_NN
adopted_VBD
SFAS_NN
133_CD
during_PIN
2001_CD
and_CC
accordingly_RB
the_DT
adjustment_NOMZ
recognized_VBN [PRIV] [WZPAST]
in_PIN
that_DEMO
year_NN
takes_VPRT
into_PIN
account_NN
the_DT
cumulative_JJ
effect_NN
of_PIN
this_DEMO
change_NN
in_PIN
accounting_GER
policy_NN
._.
vii_FW
Deferred_JJ
taxation_NOMZ
The_DT
Group_NN
adopted_VBD
FRS_NN
19_CD
during_PIN
2001_CD
resulting_VBG
in_PIN
prior_JJ
year_NN
adjustments_NOMZ
to_PIN
goodwill_NN
and_CC
deferred_VBN
taxation_NOMZ
under_IN
UK_NN
GAAP_NN
._.
Under_IN
US_FPP1
GAAP_NN
no_SYNE
deferred_JJ
tax_NN
liability_NOMZ
is_VPRT [PASS]
recognized_VBN [PRIV]
in_PIN
a_DT
purchase_NN
business_NOMZ
combination_NOMZ
for_PIN
which_WDT [PIRE]
amortisation_NOMZ
is_VPRT [BEMA]
not_XX0
deductible_PRED
for_PIN
tax_NN
purposes_NN
._.
Consequently_CONJ
the_DT
FRS_NN
19_CD
adjustments_NOMZ
have_VPRT [PEAS]
been_VBN [PASS]
reversed_VBN
._.
viii_FW
Employee_NN
Share_NN
Ownership_NN
Plan_NN
ESOP_NN
Under_IN
UK_NN
GAAP_NN
the_DT
Companys_NN
own_JJ
shares_NN
held_VBN [PRIV] [WZPAST]
by_PIN
the_DT
ESOP_NN
are_VPRT [PASS]
recorded_VBN
as_IN
fixed_JJ
asset_NN
investments_NOMZ
at_PIN
cost_NN
._.
Under_IN
US_FPP1
GAAP_NN
those_DEMO
shares_NN
not_XX0
fully_AMP
vested_VBN
are_VPRT [PASS]
regarded_VBN
as_IN
treasury_NN
stock_NN
and_CC
recorded_VBN
at_PIN
cost_NN
as_IN
a_DT
deduction_NOMZ
from_PIN
shareholders_NN
equity_NOMZ
._.
ix_NN
Pensions_NN
other_JJ
comprehensive_JJ
income_NN
Under_IN
US_FPP1
GAAP_NN
,_,
a_DT
minimum_JJ
pension_NN
liability_NOMZ
is_VPRT [PASS]
recognized_VBN [PRIV]
through_PIN
other_JJ
comprehensive_JJ
income_NN
in_PIN
certain_JJ
circumstances_NN
when_RB
there_EX
is_VPRT
a_DT
deficit_NN
of_PIN
plan_NN
assets_NN
relative_JJ
to_PIN
the_DT
projected_VBN
benefits_NN
obligation_NOMZ
._.
Under_IN
UK_NN
GAAP_NN
,_,
there_EX
is_VPRT
no_SYNE
such_JJ
requirement_NOMZ
._.
